📣 VC round data is live. Check it out!

Fukuda Denshi Valuation Multiples

Discover Fukuda Denshi's revenue and EBITDA valuation multiples and investment history, alongside public comparables like MicroPort, Bausch Health, AddLife, MicroPort Scientific and more.

Fukuda Denshi Overview

About Fukuda Denshi

Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm’s devices. Fukuda Denshi generates the vast majority of its sales in Japan.


Founded

1948

HQ

Japan

Employees

3.8K

Financials (LTM)

Revenue: $881M
Net Income: $117M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Fukuda Denshi Financials

Fukuda Denshi reported last 12-month revenue of $881M.

In the same LTM period, Fukuda Denshi generated $475M in gross profit and $117M in net income.

Revenue (LTM)


Fukuda Denshi P&L

In the most recent fiscal year, Fukuda Denshi reported revenue of $871M and EBITDA of $236M.

Fukuda Denshi is profitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 27%, and net margin of 13%.

See analyst estimates for Fukuda Denshi
LTMLast FY202320242025202620272028
Revenue$881M$871M$870M$873M$877M
Gross Profit$475M$462M$460M$463M$472M
Gross Margin54%53%53%53%54%
EBITDA-$236M$227M$235M$236M
EBITDA Margin-27%26%27%27%
EBIT Margin19%19%19%19%19%
Net Profit$117M$117M$115M$117M$118M
Net Margin13%13%13%13%13%

Financial data powered by Morningstar, Inc.

Fukuda Denshi Stock Performance

Fukuda Denshi has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Fukuda Denshi's stock price is $72.48.

Fukuda Denshi share price decreased by 1.1% in the last 30 days, and increased by 64.5% in the last year.

Fukuda Denshi has an EPS (earnings per share) of $4.31.

See more trading valuation data for Fukuda Denshi
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B0.4%-1.1%19.0%64.5%$4.31

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Fukuda Denshi Valuation Multiples

Fukuda Denshi trades at 1.8x EV/Revenue multiple, and 6.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Fukuda Denshi

EV / Revenue (LTM)


Fukuda Denshi Financial Valuation Multiples

As of June 3, 2026, Fukuda Denshi has market cap of $2B and EV of $2B.

Fukuda Denshi has a P/E ratio of 16.8x.

LTMLast FY202320242025202620272028
EV/Revenue1.8x1.8x1.8x1.8x1.8x
EV/EBITDA-6.6x6.9x6.7x6.6x
EV/EBIT9.5x9.7x9.7x9.6x9.4x
EV/Gross Profit3.3x3.4x3.4x3.4x3.3x
P/E16.8x16.8x17.0x16.8x16.6x
EV/FCF22.5x12.4x25.1x14.3x19.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Fukuda Denshi Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Fukuda Denshi Margins & Growth Rates

Fukuda Denshi grew revenue by 1% and net profit by 1% in the last fiscal year.

In the most recent fiscal year, Fukuda Denshi reported gross margin of 53%, EBITDA margin of 27%, and net margin of 13%.

See estimated margins and future growth rates for Fukuda Denshi

Fukuda Denshi Margins

Last FY202420252026202720282029
Gross Margin53%53%54%54%
EBITDA Margin27%27%27%-
EBIT Margin19%19%19%18%
Net Margin13%13%13%13%
FCF Margin14%13%9%8%

Fukuda Denshi Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth1%0%1%1%
Gross Profit Growth3%1%2%1%
EBITDA Growth-4%1%-
EBIT Growth3%0%2%(4%)
Net Profit Growth1%2%1%(5%)
FCF Growth(46%)76%(25%)(9%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Fukuda Denshi Operational KPIs

Fukuda Denshi's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Fukuda Denshi
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.1M---
Opex to Revenue34%34%34%34%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Fukuda Denshi Competitors

Fukuda Denshi competitors include MicroPort, Bausch Health, AddLife, MicroPort Scientific, Establishment Labs, NovoCure, Mehow Innovative, LeMaitre Vascular, Axogen and Embla Medical.

Most Fukuda Denshi public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
MicroPort8.0x7.4x14.7x13.8x
Bausch Health2.1x2.1x6.0x5.8x
AddLife2.0x2.0x11.9x12.2x
MicroPort Scientific2.4x2.3x16.6x14.0x
Establishment Labs10.7x9.7x(159.9x)(2593.1x)
NovoCure2.5x2.4x(47.6x)(73.6x)
Mehow Innovative7.7x7.0x29.1x26.4x
LeMaitre Vascular7.7x7.3x21.1x23.5x

This data is available for Pro users. Sign up to see all Fukuda Denshi competitors and their valuation data.

Start Free Trial

Investments by Fukuda Denshi

Fukuda Denshi has invested in 1 company to date.

Latest investment by Fukuda Denshi was on January 31st 2025. Fukuda Denshi invested in CROSS SYNC in their $1M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Fukuda Denshi

CROSS SYNC
Description
CROSS SYNC is a Tokyo-based developer of AI-driven healthcare software for intensive care units. Its flagship platform aggregates vital signs from bedside monitors, ventilators, and lab results to predict deteriorations like sepsis or cardiac events up to six hours in advance. Deployed in Japanese hospitals, the system shares dashboards with physicians, nurses, patients, and families to coordinate interventions across wards and remote sites.
HQ CountryJapan
HQ City
Nishi
Deal Date31 Jan 2025
RoundSeries A
Raised$1M
InvestorsFukuda Denshi; IT-Farm
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Fukuda Denshi investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Fukuda Denshi

When was Fukuda Denshi founded?Fukuda Denshi was founded in 1948.
Where is Fukuda Denshi headquartered?Fukuda Denshi is headquartered in Japan.
How many employees does Fukuda Denshi have?As of today, Fukuda Denshi has over 3K employees.
Is Fukuda Denshi publicly listed?Yes, Fukuda Denshi is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Fukuda Denshi?Fukuda Denshi trades under 6960 ticker.
When did Fukuda Denshi go public?Fukuda Denshi went public in 1982.
Who are competitors of Fukuda Denshi?Fukuda Denshi main competitors include MicroPort, Bausch Health, AddLife, MicroPort Scientific, Establishment Labs, NovoCure, Mehow Innovative, LeMaitre Vascular, Axogen, Embla Medical.
What is the current market cap of Fukuda Denshi?Fukuda Denshi's current market cap is $2B.
What is the current revenue of Fukuda Denshi?Fukuda Denshi's last 12 months revenue is $881M.
What is the current revenue growth of Fukuda Denshi?Fukuda Denshi revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Fukuda Denshi?Current revenue multiple of Fukuda Denshi is 1.8x.
What is the current net income of Fukuda Denshi?Fukuda Denshi's last 12 months net income is $117M.
What is the current FCF of Fukuda Denshi?Fukuda Denshi's last 12 months FCF is $70M.
What is Fukuda Denshi's FCF margin?Fukuda Denshi's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of Fukuda Denshi?Current FCF multiple of Fukuda Denshi is 22.5x.
How many companies Fukuda Denshi has acquired to date?Fukuda Denshi hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Fukuda Denshi has invested to date?As of June 2026, Fukuda Denshi has invested in 1 company.
In what companies Fukuda Denshi invested in?Fukuda Denshi invested in CROSS SYNC.

See public comps similar to Fukuda Denshi

Lists including Fukuda Denshi

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial